NCB-02 (standardized Curcumin preparation) protects dinitrochlorobenzene- induced colitis through down-regulation of NFkappa-B and iNOS.
about
Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A ReviewDietary agents and phytochemicals in the prevention and treatment of experimental ulcerative colitisLimited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection.Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity.Curcumin and the cellular stress response in free radical-related diseases.A neutraceutical by design: the clinical application of curcumin in colonic inflammation and cancer.Naringin ameliorates acetic acid induced colitis through modulation of endogenous oxido-nitrosative balance and DNA damage in rats.Therapeutic potential of curcumin in gastrointestinal diseases.Bone, inflammation, and inflammatory bowel disease.Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations.Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkersCurcumin half analog modulates interleukin-6 and tumor necrosis factor-alpha in inflammatory bowel disease.Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease.Curcumin reverses attenuated carbachol-induced contraction of the colon in a rat model of colitis.Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease.Of mice and men: a novel dietary supplement for the treatment of ulcerative colitis.Efficacy of bio-optimized extracts of turmeric and essential fennel oil on the quality of life in patients with irritable bowel syndrome
P2860
Q26998841-70DDF79F-A369-4F4D-986C-D9E7F3D2BB09Q27021100-4D4D8601-F8A4-49FB-AF6E-F4C2802D28BDQ36977052-7E7A6DC9-3499-4336-A209-1D5D462112BFQ37217435-B7A5CDD4-C9F4-4694-A0A7-4EF484A2D0B2Q37268964-87158202-F0E6-4C8B-B2EB-01A860CACFF2Q37288656-DC9040DE-4C64-4DFB-BA12-B13CBE364BC7Q37669820-5D25D0CB-CBF3-4F18-B39A-78DAC328A44EQ37878888-35209631-A1C3-4B77-8695-754C8D977F5EQ37936285-97814BEA-D499-44B1-A46B-C5EE1D406D0BQ38029557-BC3CE063-FC35-4F90-ABB7-7E4EF54A9826Q38083084-2B8CFFA6-9466-41F0-8FAB-FC3CDEAF27BDQ41785133-349B0BD4-FEF1-4B38-BD48-71B60E6F4520Q41858578-CFEA8647-7F07-417E-B4D9-CC7851883489Q46335277-E3490C4F-C65F-4710-B849-E0ACAA22252AQ48097176-F4F25E47-9F8E-4374-B397-E132E0FCCF20Q49570191-1814AA4C-BC04-43D4-9DAE-7AF8CF7AA457Q58541822-A05570C8-B0F5-4DF5-9C53-724CC72F1F7B
P2860
NCB-02 (standardized Curcumin preparation) protects dinitrochlorobenzene- induced colitis through down-regulation of NFkappa-B and iNOS.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
NCB-02 (standardized Curcumin ...... ulation of NFkappa-B and iNOS.
@en
type
label
NCB-02 (standardized Curcumin ...... ulation of NFkappa-B and iNOS.
@en
prefLabel
NCB-02 (standardized Curcumin ...... ulation of NFkappa-B and iNOS.
@en
P2093
P2860
P356
P1476
NCB-02 (standardized Curcumin ...... ulation of NFkappa-B and iNOS.
@en
P2093
Ghouse Peer
M V Venkataranganna
S Gopumadhavan
P2860
P304
P356
10.3748/WJG.V13.I7.1103
P407
P577
2007-02-01T00:00:00Z